Friday, July 1, 2022

FDA Alert on Homemade Infant Formula from Plug Heist Trap House EST. 2017

US Food and Drug Administration

Outbreak Investigations & Safety Advisories

Center for Food Safety and Applied Nutrition 

The following is an update from FDA of concern to our subscribers.


FDA Alert on Homemade Infant Formula from Plug Heist Trap House EST. 2017

July 1, 2022

Audience

  • Parents and caregivers of infants who consume infant formula

Product

  • Product: Infant Formula from Plug Heist Trap House EST. 2017
  • Distribution: The product was sold through the firm's Facebook page, "Stephanie PlugHeist Payton."

Purpose

The FDA advises parents and caregivers of infants to stop using homemade infant formula from Plug Heist Trap House. The manufacturer was marketing this product as an infant formula with no product labeling and did not submit the required pre-market notification to the FDA. Homemade infant formulas have not been evaluated by the FDA for safety and may lack nutrients vital to an infant's growth.

Summary of Problem and Scope

The FDA has determined that this product was not manufactured in compliance with infant formula regulations, was not tested to determine if it meets the nutritional requirements for infant formula, has the potential to cause nutrient deficiencies in infants, and may be contaminated with harmful bacteria.

FDA Actions

The FDA conducted an investigation earlier this week at the location of the firm, a home residence. The firm committed to no longer manufacturing and selling the product.

Recommendations for Consumers

Parents and caregivers of infants who have purchased this product should discontinue use and throw it away.

Parents and caregivers of infants who have used this product and are concerned about the health of their child should contact their health care provider.

To report a complaint or adverse event (illness or serious allergic reaction), you can:

Visit www.fda.gov/fcic for additional consumer and industry assistance.

For More Information:

Read the full update


This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo

No comments:

Post a Comment